ASCIDIAN
Live / Registered — Registered (as of 06 Aug 2024)
What this means for you
Registered since 06 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88932933
- Registration number
- 7469116
- Mark type
- Stylized text
- Filed
- 26 May 2020
- Published for opposition
- 30 Mar 2021
- Registered
- 06 Aug 2024
- Attorney of record
- William W. Stroever
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for medical use in medical and clinical gene therapy and cell therapy
Owner
- ASCIDIAN THERAPEUTICS, INC., Boston, MA, US
- ASCIDIAN THERAPEUTICS, INC., Boston, MA, US
- ASCIDIAN THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Pulsar Biotherapeutics, Inc, Cambridge, MA, US
Prosecution history
- 06 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2024 — USE AMENDMENT FILED
- 22 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 May 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 May 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 28 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2023 — SOU EXTENSION 5 GRANTED
- 22 Nov 2023 — SOU EXTENSION 5 FILED
- 22 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 26 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED